CompletedNot Applicable

EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms

Australia, Canada, Czechia110 participantsStarted 2009-12

Plain-language summary

The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients for whom this device would be chosen in standard practice Exclusion Criteria: * Patients for whom this device would not normally be chosen in standard practice

What they're measuring

Patency of the stent

Timeframe: 14 days

Trial details

NCT IDNCT00991614

SponsorCook Group Incorporated

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2011-06

View on ClinicalTrials.gov More Duodenal Obstruction trials